MedPath

Effect of Vitamin D3 and Omega-3FA on Leptin and HbA1C With Vitamin D Deficiency

Not Applicable
Completed
Conditions
Vitamin D Deficiency
Registration Number
NCT03735303
Lead Sponsor
Applied Science Private University
Brief Summary

The Combined effect of Vitamin D3 and Omega-3 supplements on serum leptin and Glycated hemoglobin (Hb A1C) levels in Jordanian people with vitamin D deficiency.

Detailed Description

Nothing is published in the literature about effect of vitamin D3 (VD3) and omega-3 fatty acids (omega-3FA) on serum leptin and glycated hemoglobin ( HbA1C)

This study will be conducted to investigate effect of VD3 and omega-3FA alone and with each other on serum leptin and Glycated hemoglobin (Hb A1C) levels in Jordanian people with vitamin D deficiency.

This randomized, controlled clinical trial will be designed to test effects of 50,000 IU VD3 weekly and 1000 mg omega-3FA daily for eight weeks, separately and with each other, on on serum leptin and Glycated hemoglobin (Hb A1C) levels .

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
146
Inclusion Criteria
  • jordanian people aged 25-55
  • medical diagnosis of vitamin D deficiency ( VD <25 ng/ ml)
Exclusion Criteria
  • Blood disorders including
  • thalassemia
  • sickle cell disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
HbA1C8 weeks

plasma concentration of HbA1C

leptin8 weeks

serum level of leptin

VD 38 weeks

Serum level of 25-hydroxyvitamin D

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Applied Science University

🇯🇴

Amman, Jordan

Applied Science University
🇯🇴Amman, Jordan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.